Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 Legality  




2 References  













6-EAPB







Add links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  



In other projects  


●Wikimedia Commons
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

6-EAPB
Legal status
Legal status
  • AU: Analogue of MDMA
  • CA: Schedule I
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class B
  • US: Analogue to a Schedule I/II drug (MDMA)
    • Identifiers

    • 1-(benzofuran-6-yl)-N-ethylpropan-2-amine

    CAS Number
    ChemSpider
    UNII
    Chemical and physical data
    FormulaC13H17NO
    Molar mass203.285 g·mol−1
    3D model (JSmol)

    • CCNC(CC1=CC2=C(C=CO2)C=C1)C

    • InChI=1S/C13H17NO.ClH/c1-3-14-10(2)8-11-4-5-12-6-7-15-13(12)9-11;/h4-7,9-10,14H,3,8H2,1-2H3;1H

    • Key:MUFUSNCKTVRMLR-UHFFFAOYSA-N

    6-EAPB (1-(benzofuran-6-yl)-N-ethylpropan-2-amine) is a potentially psychedelic and potentially entactogenic drug of the benzofuran class;[1] it is structurally related to 6-APB and MDMA.

    Legality[edit]

    As an N-ethyl derivative of 6-APB, 6-EAPB fell outside the scope of the Temporary Class Drug ban issued by the Home Office on June 10, 2013.[2] The ACMD has advised that 6-EAPB (and other benzofurans) are moved to Class B,[3] this came into action on 10 June 2014.[4]

    References[edit]

    1. ^ Taschwer M, Hofer MG, Schmid MG (October 2014). "Enantioseparation of benzofurys and other novel psychoactive compounds by CE and sulfobutylether β-cyclodextrin as chiral selector added to the BGE". Electrophoresis. 35 (19): 2793–2799. doi:10.1002/elps.201400164. PMID 24930967. S2CID 2937770.
  • ^ "Temporary class drug order on benzofury and NBOMe compounds". Retrieved 15 June 2015.
  • ^ "ACMD recommends permanent ban on two "legal highs"". Retrieved 15 June 2015.
  • ^ "Ban on NBOMe and benzofurans comes into force". Retrieved 15 June 2015.


    • Stub icon

    This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=6-EAPB&oldid=1215461234"
    Categories: 
    ●Substituted amphetamines
     ●6-Benzofuranethanamines
     ●Designer drugs
     ●Serotonin-norepinephrine-dopamine releasing agents
     ●Serotonin receptor agonists
     ●Entactogens and empathogens
     ●Hallucinogen stubs
     Hidden categories: 
    ●Articles with short description
     ●Short description is different from Wikidata
     ●Drugs with non-standard legal status
     ●Articles without EBI source
     ●Chemical pages without DrugBank identifier
     ●Articles without KEGG source
     ●Drugs missing an ATC code
     ●Articles containing unverified chemical infoboxes
     ●All stub articles
      


    ●This page was last edited on 25 March 2024, at 07:47 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki